SURUNKALI VIRUSLI GEPATIT B VA C BILAN OG‘RIGAN BEMORLARDA PARODONTITNI DAVOLASH VA PROFILAKTIKA QILISHDA KOMPLEKS IMMUNOMODULYATOR TERAPIYANING KLINIK SAMARADORLIGI

Authors

  • Ismoilov Axrorjon Anvarjon o‘g‘li Author
  • Sadriyev Nizom Najmiddinovich Author

Keywords:

parodontit, immunomodulyator terapiya, antioksidantlar, klinik indekslar, gepatit B va C

Abstract

Mazkur tezis surunkali virusli gepatit fonida kechuvchi parodontitni davolashda kompleks, patogenetik asoslangan immunomodulyator yondashuv samaradorligini baholashga bag‘ishlangan. Klinik, immunologik va biokimyoviy ko‘rsatkichlar dinamikasi asosida ishlab chiqilgan davolash sxemasining ustunliklari asoslab berilgan.

References

1. Ebersole J.L., Kirakodu S.S. Systemic immunity in periodontal disease. J Oral Microbiology, 2021.

2. Bui F.Q. et al. Cytokines in periodontal disease. Frontiers in Immunology, 2019.

3. Tonetti M.S. et al. Classification of periodontitis. Journal of Periodontology, 2018.

4. World Health Organization. Global Hepatitis Report, 2021.

5. Kinane D. et al. Periodontal diseases. Nature Reviews Disease Primers, 2017.

Downloads

Published

2026-02-07

Issue

Vol. 89 No. 2 (2026): USTOZLAR UCHUN | pedagoglar jurnali | 89-son | 2-to'plam

Section

Articles

How to Cite

[1]
2026. SURUNKALI VIRUSLI GEPATIT B VA C BILAN OG‘RIGAN BEMORLARDA PARODONTITNI DAVOLASH VA PROFILAKTIKA QILISHDA KOMPLEKS IMMUNOMODULYATOR TERAPIYANING KLINIK SAMARADORLIGI. Ustozlar uchun. 89, 2 (Feb. 2026), 106–108.